VNDA — Vanda Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousSmall CapNeutral

Annual balance sheet for Vanda Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	433	467	388	375	264
Net Total Accounts Receivable
Net Total Receivables	32.5	33.5	34.2	47.1	54.6
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	478	519	433	439	347
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	12.4	11	9.14	12.7	13.5
Net Intangible Assets
Other Long Term Assets
Total Assets	594	634	648	656	489
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	74.4	91.4	87.7	100	145
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	88.9	107	104	118	162
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Unrealized Gain / Loss
Other Equity
Total Equity	505	527	545	539	327
Total Liabilities & Shareholders' Equity	594	634	648	656	489
Total Common Shares Outstanding